Evidence map›Paper›PMID 40166338›Full record

ArticlebioRxiv : the preprint server for biology2025

Chemoselective Characterization of New Extracellular Matrix Deposition in Bioengineered Tumor Tissues.

Zihan Ling, Burke Niego, Qingyang Li, Vanessa Serna Villa, Dhruv Bhattaram, Michael Hu, Zhuowei Gong, Lloyd M Smith, Brian L Frey, Xi Ren

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Zihan LingDepartment of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania, United States.ORCID 0009-0004-6152-0736
Burke NiegoDepartment of Chemistry, University of Wisconsin, Madison, Wisconsin, United States.
Qingyang LiDepartment of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania, United States.
Vanessa Serna VillaDepartment of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania, United States.
Dhruv BhattaramDepartment of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania, United States.
Michael HuDepartment of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania, United States.
Zhuowei GongDepartment of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania, United States.
Lloyd M SmithDepartment of Chemistry, University of Wisconsin, Madison, Wisconsin, United States.
Brian L FreyDepartment of Chemistry, University of Wisconsin, Madison, Wisconsin, United States.
Xi RenDepartment of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania, United States.

Funding

Institutional Training in the Genomic SciencesT32HG002760 · NHGRI · UNIVERSITY OF WISCONSIN-MADISON · PI Qiongshi Lu · 2003 to 2026
$17.7M
Sequence-specific Hybridization Capture to Reveal the lncRNA Interactome in Prostate CancerR01CA193481 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI DAVID F. JARRARD, Lloyd M Smith · 2015 to 2026
$3.4M
Discovering Extracellular Modulators of Lung Fibrogenesis by Profiling Newly Synthesized Extracellular MatrixR56HL158969 · NHLBI · CARNEGIE-MELLON UNIVERSITY · PI REN, XI · 2022 to 2022
$596k
NCI NIH HHS R01 CA193481NHGRI NIH HHS T32 HG002760NHLBI NIH HHS R56 HL158969
6 · The paper itself

Abstract

The extracellular matrix (ECM), present in nearly all tissues, provides extensive support to resident cells through structural, biomechanical, and biochemical means, and in return the ECM undergoes constant remodeling from interacting cells to adapt to the evolving tissue states. Bioengineered 3D tissues, commonly known as cell-ECM composites, are robust model systems to recapitulate and investigate native pathophysiology. Key to this engineered morphogenesis process are the intricate cell-ECM interactions reflected by how cells respond to and thereby modulate their surrounding microenvironments through their ongoing ECM secretome. However, investigating ECM-regulated new ECM production has been challenging due to the proteomic background from the pre-existing biomaterial ECM. To address this hindrance, here we present a chemoselective strategy to label, enrich, and characterize newly synthesized ECM (newsECM) proteins produced by resident cells, allowing distinction from the pre-existing ECM background. Applying our analytical pipeline to bioengineered tumor tissues, either built upon decellularized ECM (dECM-tumors) or as ECM-free tumor spheroids (tumoroids), we observed distinct ECM synthesis patterns that were linked to their extracellular environments. Tumor cells responded to the dECM presence with elevated ECM remodeling activities, mediated by augmented digestion of pre-existing ECM coupled with upregulated synthesis of tumor-associated ECM. Our findings highlight the sensitivity of newsECM profiling to capture remodeling events that are otherwise under-represented by bulk proteomics and underscore the significance of dECM support for enabling native-like tumor cell behaviors. We anticipate the described newsECM analytical pipeline to be broadly applicable to other tissue-engineered systems to probe ECM-regulated ECM synthesis and remodeling, both fundamental aspects of cell-ECM crosstalk in engineered tissue morphogenesis.

Indexed as

BiomaterialChemoselective chemistryNewly-synthesized extracellular matrixProteomics

Identifiers

PMID40166338
PMCPMC11956949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.